Simplex Trading
ZYME icon

Simplex Trading’s Zymeworks ZYME Stock Holding History

Simplex Trading’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.7K Sell
600
-4,800
-89% -$122K ﹤0.01% 7321
2026
Q1 		$135K Sell
5,400
-3,900
-42% -$92.3K ﹤0.01% 4744
2025
Q4 		$245K Sell
9,300
-23,900
-72% -$521K ﹤0.01% 4020
2025
Q3 		$567K Buy
33,200
+7,800
+31% +$112K ﹤0.01% 3669
2025
Q2 		$318K Sell
25,400
-5,700
-18% -$67.9K ﹤0.01% 4008
2025
Q1 		$370K Buy
31,100
+30,700
+7,675% +$419K ﹤0.01% 3731
2024
Q4 		$5K Sell
400
-1,000
-71% -$14K ﹤0.01% 7682
2024
Q3 		$17K Sell
1,400
-1,500
-52% -$16.3K ﹤0.01% 6820
2024
Q2 		$24K Sell
2,900
-18,600
-87% -$166K ﹤0.01% 6752
2024
Q1 		$226K Buy
21,500
+17,900
+497% +$199K ﹤0.01% 4717
2023
Q4 		$37K Buy
3,600
+200
+6% +$1.59K ﹤0.01% 6383
2023
Q3 		$21K Sell
3,400
-5,100
-60% -$37.7K ﹤0.01% 6594
2023
Q2 		$73K Sell
8,500
-22,100
-72% -$198K ﹤0.01% 5447
2023
Q1 		$276K Buy
30,600
+14,100
+85% +$123K ﹤0.01% 3942
2022
Q4 		$129K Sell
16,500
-47,900
-74% -$337K ﹤0.01% 4777
2022
Q3 		$396K Buy
64,400
+60,300
+1,471% +$363K ﹤0.01% 3742
2022
Q2 		$21K Buy
4,100
+2,500
+156% +$15.1K ﹤0.01% 7571
2022
Q1 		$10K Sell
1,600
-30,600
-95% -$273K ﹤0.01% 8912
2021
Q4 		$527K Buy
32,200
+30,100
+1,433% +$628K ﹤0.01% 3713
2021
Q3 		$78K Buy
2,100
+1,100
+110% +$36.6K ﹤0.01% 6965
2021
Q2 		$34K Buy
1,000
+983
+5,782% +$31.2K ﹤0.01% 8121
2021
Q1 		$53K Buy
17
+10
+143% +$406 ﹤0.01% 6549
2020
Q4 		$33K Sell
7
-108
-94% -$5.01K ﹤0.01% 6598
2020
Q3 		$535K Buy
115
+82
+248% +$2.82K ﹤0.01% 2919
2020
Q2 		$119K Sell
33
-33
-50% -$1.22K ﹤0.01% 4621
2020
Q1 		$234K Buy
66
+54
+450% +$2.21K ﹤0.01% 3423
2019
Q4 		$54K Hold
12
– – ﹤0.01% 5121
2019
Q3 		$29K Buy
12
+1
+9% +$25 ﹤0.01% 5529
2019
Q2 		$24K Buy
11
+6
+120% +$110 ﹤0.01% 5481
2019
Q1 		$8K Buy
+5
New +$78 ﹤0.01% 6296

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Simplex Trading's ZYME Position: Q2 2026 in Review

Simplex Trading increased its Zymeworks (ZYME) stake by 1,354% in Q2 2026, buying an estimated $460K and bringing the position to 19,431 shares worth $508K. The position accounts for ﹤0.01% of the portfolio, ranked #3586.

Simplex Trading first reported a position in ZYME in Q4 2018 and has held it in 26 quarters since. The position peaked at $1.79M in Q4 2019. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Simplex Trading held 19,431 shares of Zymeworks worth $508K as of Q2 2026.
  • Simplex Trading bought 18,095 Zymeworks shares in Q2 2026, an estimated $460K.
  • Zymeworks made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #3586 holding.
  • Simplex Trading first reported a position in Zymeworks in Q4 2018 and has held it in 26 quarters since.
  • Simplex Trading's Zymeworks position peaked at $1.79M in Q4 2019.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.